Evidence map›Paper›PMID 31955292›Full record

ArticleInflammation2020

Anti-Cancer and Anti-Inflammatory Activities of Bromo- and Cyano-Substituted Azulene Derivatives.

Furkan Ayaz, Abdulcelil Yuzer, Tuncay Ince, Mine Ince

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Essential Oil ofClinical, cosmetic and investigational dermatology · 2024
    Article
  4. International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Food science & nutrition · 2021
    Article
  8. Molecules (Basel, Switzerland) · 2020
    Article
  9. Review
  10. Article
  11. Extract ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Furkan AyazDepartment of Biotechnology, Faculty of Arts and Science, Mersin University, 33110, Mersin, Turkey. furkanayaz@mersin.edu.tr.ORCID http://orcid.org/0000-0003-0271-0594
Abdulcelil YuzerAdvanced Technology Research & Application Center, Mersin University, Ciftlikkoy Campus, TR-33343, Mersin, Turkey.
Tuncay InceAdvanced Technology Research & Application Center, Mersin University, Ciftlikkoy Campus, TR-33343, Mersin, Turkey.
Mine InceDepartment of Energy Systems Engineering Faculty of Tarsus Technology, Tarsus University, 33400, Mersin, Turkey. mine.ince@tarsus.edu.tr.
Mersin Üniversitesi · TRTarsus University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products and their synthetic derivatives gathered attention due to their pharmaceutical capacities. They have been in use against different types of diseases ranging from cancer to inflammatory disorders. In order to increase their efficacy and prevent the possible side effects, these natural compounds are manipulated at the laboratory conditions and modified according to our needs. Azulene is one of these compounds whose anti-inflammatory potential have been shown by the previous studies, but a detailed analysis of its effect at the cellular level in terms of pro-inflammatory cytokine production has not been studied yet. Moreover, its derivative potential has not been characterized extensively. In our study, we examined the cytotoxic, immunomodulatory and immunostimulatory potential of bromo- and cyano-substituted azulenes on the mammalian macrophages. These unique compounds had differential effects on the production of pro-inflammatory cytokines and they were anti-inflammatory immunomodulators. Furthermore, they exerted anti-proliferative effect on breast and prostate cancer cells which supports their anti-cancer potential as well.

Indexed as

AnimalsAnti-Inflammatory AgentsAntineoplastic AgentsAzulenesCell SurvivalHumansLipopolysaccharidesMacrophagesMCF-7 CellsMiceRAW 264.7 CellsAnti-Inflammatory AgentsAntineoplastic AgentsAzulenesLipopolysaccharidesazulenebreast cancerinflammationmacrophagesprostate cancer

Identifiers

PMID31955292
OpenAlexW3000617705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.